[1] Arroyo V,Jalan R.Acute-on-chronic liver failure:definition,diagnosis,and clinical characteristics. Semin Liver Dis,2016,36(2):109-116. [2] Li H,Chen LY,Zhang NN,et al.Characteristics,diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B. Sci Rep,2016,6:25487. [3] Tripodi A,Primignani M,Lemma L,et al.Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method. Hepatology,2010,52(1):249-255. [4] Tripodi A,Primignani M,Chantarangkul V,et al.An imbalance of pro-vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology,2009,137(6):2105-2111. [5] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版). 实用肝脏病杂志,2013,16(3):210-216. [6] 张野,聂青和. 1892例肝衰竭患者并发症及死亡原因分析. 实用肝脏病杂志,2014,17(2):129-132. [7] Rao AK,Pratt C,Berke A,et al.Thrombolysis in myocardial infarction(TIMI) trial-phase I:Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol,1988,11(1):1-11. [8] Mehran R,Rao SV,Bhatt DL,et al.Standardized bleeding defi-nitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation,2011,123(23):2736-2747. [9] An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med,1993,329(10):673-682. [10] Park JG,Lee YR,Park SY,et al.Tenofovir,entecavir,and lamivudine in patients with severe acute exacerbation and hepatic decompensation of chronic hepatitis B. Dig Liver Dis,2018,50(2):163-167. [11] Sarin SK,Kumar A,Almeida JA,et al.Acute-on-chronic liver failure:consensus recommendations of the asian pacific association for the study of the liver (APASL). Hepatol Int,2009,3(1):269-282. [12] Moreau R,Jalan R,Gines P,et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology,2013,144(7):1426-1437,1431-1437. [13] Beyer-Westendorf J,Forster K,Pannach S,et al.Rates,management,and outcome of rivaroxaban bleeding in daily care:results from the Dresden NOAC registry. Blood,2014,124(6):955-962. [14] Figorilli F,Putignano A,Roux O,et al.Development of an organ failure score in acute liver failure for transplant selection and identification of patients at high risk of futility. PLoS One,2017,12(12):e188151. [15] Choi JH,Seo JM,Lee DH,et al.Clinical utility of new bleeding criteria:a prospective study of evaluation for the bleeding academic research consortium definition of bleeding in patients undergoing percutaneous coronary intervention. J Cardiol,2015,65(4):324-329. [16] Vranckx P,Leonardi S,Tebaldi M,et al.Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial. Eur Heart J,2014,35(37):2524-2529. [17] 季淑静,王梦洁,陈金军. 慢加急性乙型肝炎肝衰竭患者贫血特点分析. 实用肝脏病杂志,2016,19(1):55-59. [18] Lang E,Gatidis S,Freise NF,et al.Conjugated bilirubin triggers anemia by inducing erythrocyte death. Hepatology,2015,61(1):275-284. |